CYP2E1 and fatty liver disease: To clarify the molecular mechanism by which probiotics decreased the oxidative stress in VPA-treated mice, we first explored the level of CYP2E1, which has been demonstrated to promote ROS production and liver steatosis in VPA-treated mice [8].